Based on these reports, we assume that the gp120-induced activation of glycolysis and cell proliferation might result from activation of cell surface signaling molecules, such as CXCR4 or CCR5 and further-downstream signaling activation in glioma cells. Here, CCR5 is linked to central nervous system cancer.